Roundtable Discussion: Refining Patient Stratification & Endpoint Selection To Improve Trial Precision & Enhance Development Efficiency

Step away from the slide decks and join informal, peer-led discussion groups. Share experiences, debate novel methodologies, and benchmark strategies with your peers in an intimate, high-value networking environment.

• Assessing how biomarker-driven patient stratification strategies can reduce heterogeneity and improve therapeutic signal detection in clinical studies
• Exploring emerging endpoint approaches that better capture disease progression and treatment impact, enabling stronger efficacy assessment
• Discussing how sponsors can balance scientific rigor, operational feasibility and regulatory expectations to optimize future trial design

Speakers:

Jen-Chieh (Jay) Chuang

Global Program Lead & Translational Medicine, Biomarker Lead, Liver diseases

Takeda